Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease.

MLA

Takanashi, Satoshi, et al. “Usefulness of Serum Krebs von Den Lungen-6 for the Management of Myositis-Associated Interstitial Lung Disease.” Rheumatology (Oxford, England), vol. 58, no. 6, June 2019, pp. 1034–39. EBSCOhost, https://doi.org/10.1093/rheumatology/key420.

APA

Takanashi, S., Nishina, N., Nakazawa, M., Kaneko, Y., & Takeuchi, T. (2019). Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease. Rheumatology (Oxford, England), 58(6), 1034–1039. https://doi.org/10.1093/rheumatology/key420

Chicago

Takanashi, Satoshi, Naoshi Nishina, Maho Nakazawa, Yuko Kaneko, and Tsutomu Takeuchi. 2019. “Usefulness of Serum Krebs von Den Lungen-6 for the Management of Myositis-Associated Interstitial Lung Disease.” Rheumatology (Oxford, England) 58 (6): 1034–39. doi:10.1093/rheumatology/key420.